Investigational drug · Phase 3
Fasedienol
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Social Anxiety Disorder, Social Anxiety Disorder (SAD).
Phase 3Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
0 still active
All registered trials
3
Any phase or sponsor naming "Fasedienol"
First trial start
2024
Mar 28, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "Fasedienol", any sponsor or status.
Conditions studied
As listed on its trial records.
- Social Anxiety Disorder
- Social Anxiety Disorder (SAD)
Approved drugs for the same conditions: Anxiety disorders · Psychiatry
Largest trials
Live from ClinicalTrials.gov: studies naming "Fasedienol" as an intervention, largest first.
- Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)Pivotal-lookingCompleted
VistaGen Therapeutics, Inc.Industry
NCT06358651 · 238 participants · Start Mar 28, 2024 · Primary completion Oct 31, 2025
Drug: Fasedienol Nasal Spray; Placebo Nasal Spray · For: Social Anxiety Disorder
Sites: Phoenix, Arizona; Fayetteville, Arkansas; Little Rock, Arkansas · 24 sites in all
- Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)Pivotal-lookingCompleted
VistaGen Therapeutics, Inc.Industry
NCT06615557 · 238 participants · Start Sep 16, 2024 · Primary completion Apr 21, 2026
Drug: Fasedienol Nasal Spray; Placebo Nasal Spray · For: Social Anxiety Disorder (SAD)
Sites: Phoenix, Arizona; Little Rock, Arkansas; Bellflower, California · 26 sites in all
VistaGen Therapeutics, Inc.Industry
NCT06809179 · 61 participants · Start Jan 9, 2025 · Primary completion Jun 12, 2026
Drug: Fasedienol Nasal Spray - Placebo Nasal Spray; Fasedienol Nasal Spray - Fasedienol Nasal Spray and 1 more · For: Social Anxiety Disorder
Sites: Sherman Oaks, California; Walnut Creek, California; Largo, Florida · 9 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder (SAD).
Liebowitz MR, Salmán E, Hanover R, et al. · CNS Spectr 2024
- Effect of fasedienol (PH94B) pherine nasal spray and steroidal hormones on electrogram responses and autonomic nervous system activity in healthy adult volunteers.
Monti L, Hanover R, Salmán E, et al. · Hum Psychopharmacol 2024
Also in development for Social Anxiety Disorder
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.